Skip to main navigation

Overview
News & Events
- Press Releases
- Events & Presentations
Stock
Financial Information
- SEC Filings
Governance
Investor Resources

Investors & Media

Press Releases

Press Releases

Year

March 29, 2021

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update

MONTREAL and CHARLOTTE, N.C., March 29, 2021 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today reported financial results for the fourth quarter and year

English

French

March 29, 2021

Milestone Pharmaceuticals Announces First Patient Enrolled in the ReVeRA Study, its Phase 2 Trial of Etripamil in Atrial Fibrillation and Rapid Ventricular Rate

MONTREAL and CHARLOTTE, N.C., March 29, 2021 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the first patient has been enrolled in its Phase 2

English

French

February 25, 2021

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

MONTREAL and CHARLOTTE, N.C., Feb. 25, 2021 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive

English

French

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 13 of 13

Print Page

RSS Feeds

Email Alerts

Investor Contact

Investor Contact

Search

Site - Footer Social

Site - Footer Menu

Careers | Contact Us | Privacy Policy | Terms of Use |

2021 Milestone Pharmaceuticals, Inc. All Rights Reserved.